KR950703952A - 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil) - Google Patents

부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)

Info

Publication number
KR950703952A
KR950703952A KR1019950702123A KR19950702123A KR950703952A KR 950703952 A KR950703952 A KR 950703952A KR 1019950702123 A KR1019950702123 A KR 1019950702123A KR 19950702123 A KR19950702123 A KR 19950702123A KR 950703952 A KR950703952 A KR 950703952A
Authority
KR
South Korea
Prior art keywords
cimetidine
vegetable oil
composition
pharmaceutical composition
partially cured
Prior art date
Application number
KR1019950702123A
Other languages
English (en)
Inventor
서쉴 샤우한
고든 프랜스
죤 뷰흘러
Original Assignee
데이비드 로버츠
스미스클라인 비참 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이비드 로버츠, 스미스클라인 비참 피엘씨 filed Critical 데이비드 로버츠
Publication of KR950703952A publication Critical patent/KR950703952A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 부분 경화된 식물성 오일이 코팅된 시메티딘 과립을 포함하는 제약조성물에 관한 것이다.

Description

부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 부분 경화된 식물성 오일 또는 그의 화학적 등가물이 시메티딘의 20중량% 이상에 해당하는 양으로 코팅된 시메티딘 과립을 포함하는 제약 조성물.
  2. 제1항에 있어서, 상기 부분 경화된 식물성 오일이 시메티딘의 50 내지 150중량% 바람직하게는 75 내지 125중량%의 양으로 존재하는 조성물.
  3. 제1또는 2항에 있어서, 상기 오일이 부분 경화된 면실유 또는 부분 경화된 대두유 또는 그의 혼합물인 조성물.
  4. 제1내지 3항 중 어느 한 항 기재의 코팅된 시메티딘 과립 및 현탁제를 포함하는 조제가능한 분말 제약 조성물.
  5. 제4항에 있어서, 계면활성제를 추가로 포함하는 조성물.
  6. 제5항에 있어서, 상기 계면활성제가 Tween 80인 조성물.
  7. 제1내지 저3항 중 어느 한 항 기재의 코팅된 시메티딘 과립을 포함하는 씹을 수 있는 정제.
  8. 제1내지 7항 중 어느 한 항에 있어서, 제산제를 추가로 포함하는 제약 조성물.
  9. 제1내지 8항 중 어느 한 항에 있어서, 알긴산염을 추가로 포함하는 제약 조성물.
  10. 제1내지 9항 중 어느 한 항에 있어서, 시메티콘을 추가로 포함하는 제약 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950702123A 1992-11-27 1993-11-22 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil) KR950703952A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9224855.8 1992-11-27
GB929224855A GB9224855D0 (en) 1992-11-27 1992-11-27 Pharmaceutical compositions
PCT/EP1993/003272 WO1994012180A1 (en) 1992-11-27 1993-11-22 Cimetidine granules coated with a partially hydrogenated vegetable oil

Publications (1)

Publication Number Publication Date
KR950703952A true KR950703952A (ko) 1995-11-17

Family

ID=10725759

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702123A KR950703952A (ko) 1992-11-27 1993-11-22 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)

Country Status (10)

Country Link
US (1) US5597844A (ko)
EP (1) EP0670722A1 (ko)
JP (1) JPH08503482A (ko)
KR (1) KR950703952A (ko)
CN (1) CN1095923A (ko)
AU (1) AU5563494A (ko)
CA (1) CA2149884A1 (ko)
GB (1) GB9224855D0 (ko)
WO (1) WO1994012180A1 (ko)
ZA (1) ZA938825B (ko)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001795A1 (en) * 1993-07-06 1995-01-19 Merck & Co., Inc. H2 antagonist-alginate-antacid combinations
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US20010014340A1 (en) * 1996-06-14 2001-08-16 Motohiro Ohta Intrabuccally rapidly disintegrating tablet
FR2753904B1 (fr) 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6242019B1 (en) * 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
EP1364584B1 (en) * 1997-08-14 2005-10-26 Cadbury Adams USA LLC Taste modified hard confectionery compositions containing functional ingredients
US6692767B2 (en) 1997-09-19 2004-02-17 Shire Laboratories Inc. Solid solution beadlet
IN186245B (ko) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
AU5904698A (en) * 1997-12-29 1999-07-19 Procter & Gamble Company, The Tablet composition
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
BR9912533A (pt) * 1998-07-31 2002-02-13 Otsuka Pharma Co Ltd Composição farmacêutica tendo sabor melhorado
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
ATE288257T1 (de) 1999-04-06 2005-02-15 Ethypharm Sa Trinkbare pharmazeutische suspension von ibuprofen
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
RU2246293C2 (ru) 1999-06-14 2005-02-20 Космо С.П.А. Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
GB2398221B (en) * 2001-10-26 2006-04-12 John Kohnke Dosage system & dosage vehicle therefor
AUPS244002A0 (en) 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
AU2004294813A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
EP1689368B1 (en) * 2003-12-04 2016-09-28 Bend Research, Inc Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053640A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
PT1691787E (pt) * 2003-12-04 2008-09-02 Pfizer Prod Inc Método de formação de multipartículas farmacêuticas
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
AU2005299490C1 (en) 2004-10-21 2012-01-19 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）微膠囊及包含其之組合物
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
JP6039042B1 (ja) * 2015-11-20 2016-12-07 株式会社スクウェア・エニックス 描画処理プログラム、描画処理装置、描画処理方法、発音処理プログラム、発音処理装置、及び、発音処理方法
JP2019531309A (ja) * 2016-10-19 2019-10-31 サインパス ファルマ, インク.Signpath Pharma, Inc. チャネル病を引き起こす薬物に対するｄｍｐｃ、ｄｍｐｇ、ｄｍｐｃ／ｄｍｐｇ、ｌｙｓｏｐｇ及びｌｙｓｏｐｃの防御効果
AU2017353968B2 (en) * 2016-11-01 2023-02-02 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine H2-receptor antagonist and an antacid
US20180140630A1 (en) * 2016-11-23 2018-05-24 M. Michael Wolfe Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburn
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
WO2020079610A1 (en) * 2018-10-18 2020-04-23 Johnson & Johnson Consumer Inc. Novel dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
JPH06501003A (ja) * 1990-09-13 1994-01-27 スミスクライン・ビーチャム・コーポレイション 非水性液状経口懸濁液
DE69233130T2 (de) * 1991-05-28 2005-06-02 Mcneil-Ppc, Inc. Kaubare zusammensetzung zur arzneimittelfreisetzung
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
CA2149884A1 (en) 1994-06-09
CN1095923A (zh) 1994-12-07
US5597844A (en) 1997-01-28
JPH08503482A (ja) 1996-04-16
ZA938825B (en) 1995-05-25
GB9224855D0 (en) 1993-01-13
WO1994012180A1 (en) 1994-06-09
EP0670722A1 (en) 1995-09-13
AU5563494A (en) 1994-06-22

Similar Documents

Publication Publication Date Title
KR950703952A (ko) 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)
KR840008264A (ko) 살서제 조성물
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
CA2016968A1 (en) Air freshener composition
KR940008689A (ko) 항네프로제증후군제
ATE13898T1 (de) Chemische blaehmittelzusammensetzung, ihre herstellung und anwendung.
KR840000234A (ko) (n-아세틸-파라-아미노페놀)-제산제 조성물
ES2053202T3 (es) Mamparo tubular.
AR001718A1 (es) Proceso para la producción de composiciones o componentes detergentes granulares
KR890011527A (ko) 살균성4,5-디클로로-1,2-디티올-3-온 조성물
KR930009730A (ko) 타이어 내부 이형제 조성물
JPS5324032A (en) Sublimable composition
KR920012407A (ko) 비누 조성물
ES2093740T4 (es) Formas de dosificacion solidas y estabilizadas de composiciones a base de salicilato de colina metal carboximetilcelulosa.
KR910011666A (ko) 모래를 주재로한 조성물
KR930020500A (ko) 후막 저항기 조성물
KR920021697A (ko) 맥반석 함유 분말세제 조성물
KR890017354A (ko) 박하 비누
KR870008991A (ko) 시멘트 구조물의 균열보수용 코킹제
KR920002134A (ko) 분말분사형 에어졸 조성물
KR920006246A (ko) 온돌용 세라믹 조성물
KR930002268A (ko) 플라이 애쉬(Fly Ash)와 모래를 혼합한 시멘트 조성물
KR910700043A (ko) 타정시에 있어서 응력분산 방법
KR920005859A (ko) 혼합분
TH20310A (th) Cement composition

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid